Specialty / Expertise

Genitourinary cancers

Research Interests

Current Research Projects

Research Staff

Training

Dr. Mostagehl received her MD from and PhD from Duke University, Durham, NC. She completed her Internal Medicine Residency at the University of California San Francisco, San Francisco, CA. She was a Post-Doctoral Fellow in Oncology at the University of Washington and the Fred Hutchinson Cancer Research Center, Seattle, WA.

Selected Publications:

Kalhorn TF, Page ST, Howald WN, Mostaghel EA, Nelson PS. Analysis of testosterone and dihydrotestosterone from biological fluids as teh oxime derivatives using high-performance liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom. 2007:21(19):3200-3006.

Mostaghel EA, Montgomery RB, Lin DW. The basic biochemistry and molecular events of hormone therapy. Curr Urol Rep. 2007 May;8(3):224-32. Review.

Mostaghel EA, Page ST, Lin DW, Fazli L, Coleman IM, True LD, Knudsen B, Hess DL, Nelson CC, Matsumoto AM, Bremner WJ, Gleave ME, Nelson PS. Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: therapeutic implications for castration-resistant prostate cancer. Cancer Res. 2007 May 15;67(10):5033-41.

Page ST, Lin DW, Mostaghel EA, Hess DL, True LD, Amory JK, Nelson PS, Matsumoto AM, Bremner WJ. Persistent intraprostatic androgen concentrations after medical castration in healthy men. J Clin Endocrinol Metab. 2006 Oct;91(10):3850-6.

Marks LS, Mazar NA, Mostaghel EA, Hess DL, Dorey FJ, Bostwick DG, Epstein JI, Partin AW, Veltri RW, Makarov D, Macairan ML, Nelson PS. Testosterone replacement therapy and the prostate: a randomized trial employing serial biopsies in aging men. JAMA. 2006 Nov 15;296(19):2351-61.